Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|September 6, 2000
Recombinant human alpha-glucosidase from rabbit milk in Pompe patientsH Van den Hout, A J Reuser, A G Vulto, et al.
European Journal of Cell Biology|November 1, 1985
The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical studyJ M van Dongen, R Willemsen, E I Ginns, et al.
Biochemical and Biophysical Research Communications|September 30, 1994
Deletion of exon 18 is a frequent mutation in glycogen storage disease type IIM Van der Kraan, M A Kroos, M Joosse, et al.
The Journal of Pathology|November 5, 1999
Pathological features of glycogen storage disease type II highlighted in the knockout mouse modelA G Bijvoet, H Van Hirtum, M Vermey, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 15, 1983
Determination of Gaucher's disease phenotypes with monoclonal antibodyE I Ginns, F P Tegelaers, R Barneveld, et al.
Journal of Neurology|September 1, 1988
Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cellsA T van der Ploeg, P A Bolhuis, R A Wolterman, et al.
Journal of Inherited Metabolic Disease|June 19, 2001
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milkJ M Van den Hout, A J Reuser, J B de Klerk, et al.
Journal of the Neurological Sciences|July 1, 1987
Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid alpha-glucosidaseA T van der Ploeg, M Kroos, J M van Dongen, et al.
Pageof 10